D S Goldstein

402 total citations
8 papers, 316 citations indexed

About

D S Goldstein is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D S Goldstein has authored 8 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Pathology and Forensic Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D S Goldstein's work include Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Lymphoma Diagnosis and Treatment (4 papers). D S Goldstein is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Lymphoma Diagnosis and Treatment (4 papers). D S Goldstein collaborates with scholars based in United States. D S Goldstein's co-authors include Sally J. DeNardo, Sui Shen, Gerald L. DeNardo, Linda A. Kroger, Kathleen R. Lamborn, John P. McGahan, Jerry P. Lewis, Qansy Salako, Robert T. OʼDonnell and Carol M. Richman and has published in prestigious journals such as Journal of Clinical Oncology, Thorax and Cancer Biotherapy and Radiopharmaceuticals.

In The Last Decade

D S Goldstein

8 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D S Goldstein United States 7 257 164 92 74 24 8 316
Mike Bayne United Kingdom 6 168 0.7× 106 0.6× 66 0.7× 60 0.8× 44 1.8× 9 234
Eliana La Rocca Italy 8 50 0.2× 106 0.6× 44 0.5× 116 1.6× 9 0.4× 30 278
Riccardo Galassi Italy 8 144 0.6× 24 0.1× 166 1.8× 101 1.4× 92 3.8× 15 327
Charleen Chan Wah Hak United Kingdom 5 56 0.2× 32 0.2× 58 0.6× 66 0.9× 19 0.8× 7 238
Ezio Candiani Italy 4 61 0.2× 51 0.3× 34 0.4× 100 1.4× 5 0.2× 7 215
Casey Liveringhouse United States 8 35 0.1× 48 0.3× 85 0.9× 99 1.3× 6 0.3× 27 194
Roslyn Wallace Australia 7 99 0.4× 23 0.1× 98 1.1× 149 2.0× 20 0.8× 15 224
Ivan Santi Italy 7 176 0.7× 71 0.4× 225 2.4× 48 0.6× 2 0.1× 9 295
Sonia Reccanello Italy 4 124 0.5× 38 0.2× 139 1.5× 72 1.0× 5 0.2× 6 312
Lorenzo Vinante Italy 7 100 0.4× 14 0.1× 59 0.6× 43 0.6× 4 0.2× 19 181

Countries citing papers authored by D S Goldstein

Since Specialization
Citations

This map shows the geographic impact of D S Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D S Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D S Goldstein more than expected).

Fields of papers citing papers by D S Goldstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D S Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D S Goldstein. The network helps show where D S Goldstein may publish in the future.

Co-authorship network of co-authors of D S Goldstein

This figure shows the co-authorship network connecting the top 25 collaborators of D S Goldstein. A scholar is included among the top collaborators of D S Goldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D S Goldstein. D S Goldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
OʼDonnell, Robert T., Sally J. DeNardo, A. Yuan, et al.. (2001). Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.. PubMed. 7(6). 1561–8. 42 indexed citations
2.
OʼDonnell, Robert T., Bryan R. Leigh, Scott Christensen, et al.. (1999). Radioimmunotherapy of Acquired Immunodeficiency Syndrome (AIDS) Associated Lymphoma. Cancer Biotherapy and Radiopharmaceuticals. 14(3). 167–176. 3 indexed citations
3.
OʼDonnell, Robert T., Gerald L. DeNardo, David L. Kukis, et al.. (1999). 67Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl-TETA-Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma.. PubMed. 5(10 Suppl). 3330s–3336s. 23 indexed citations
4.
Richman, Carol M., Sally J. DeNardo, Robert T. OʼDonnell, et al.. (1999). Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A.. PubMed. 5(10 Suppl). 3243s–3248s. 25 indexed citations
5.
DeNardo, Gerald L., Sally J. DeNardo, D S Goldstein, et al.. (1998). Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 16(10). 3246–3256. 146 indexed citations
6.
DeNardo, Sally J., L.F. O'Grady, Carol M. Richman, et al.. (1997). Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody.. PubMed. 17(3B). 1745–51. 49 indexed citations
7.
DeNardo, Gerald L., Kathleen R. Lamborn, Sally J. DeNardo, et al.. (1995). Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies.. PubMed. 55(23 Suppl). 5893s–5898s. 13 indexed citations
8.
Goldstein, D S & M. Henry Williams. (1986). Rate of improvement of pulmonary function in sarcoidosis during treatment with corticosteroids.. Thorax. 41(6). 473–474. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026